Accuray has appointed Steve La Neve as its new CEO, replacing current president and CEO Suzanne Winter.
La Neve's placement is effective October 20. Winter will remain in an advisory role through the end of November, Accuray said.
La Neve brings more than 40 years of international medical technology experience to his new position. He previously served as president of the trauma and joint reconstruction business unit of Globus Medical and president of Globus Medical Japan, as well as CEO of Bone Biologics Corporation, global president of Becton Dickinson Preanalytical Systems, and global sector president for Medtronic's spine and biologics division, according to Accuray.
